Susan G. Komen for the Cure® has funded more breast cancer research than any other breast cancer organization — more than $740 million to date. We do not conduct research ourselves but it is subject to strict scrutiny and review by our Medical and Scientific Affairs team.
In addition to prevention, environmental, early detection and disparities research, Komen funds studies to develop new drugs for breast cancer, with a focus on strategies to stop the spread of breast cancer or prevent it all together. Some of this research involves developing new drugs.
The U.S. Food and Drug Administration (FDA) requires that any new pharmaceutical compound be tested on at least two different animal models to be considered for approval for use in humans. Therefore, some investigators must conduct animal testing in order to comply with FDA regulations for drug development.
In order to be eligible for Komen research grant funding, investigators must provide proof of pre-approval of study design and animal care methods from the Institutional Animal Care and Use Committee (IACUC) at the institution where they will be conducting research.
IACUC assurances, available at this like: http://iacuc.org, are intended to limit animal research to only that which is unavoidable and to limit animal discomfort and injury.
Komen takes this compliance very seriously as part of our grants review and monitoring process.